Product
DDGP
1 clinical trial
1 indication
Indication
Extranodal NK/T Cell LymphomaClinical trial
The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell LymphomaStatus: Not yet recruiting, Estimated PCD: 2026-12-31